Process of using prodigiosin as an immunosuppressive
AssigneeKorea Research Institute of Bioscience and Biotechnology
InventorsHwanmook Kim, Youngkook Kim, Sangbae Han, Sungrak Yoo
Life of this patent
Estimating the term…
Abstract
There are disclosed a novel microorganism Serratia marcescens strain and a prodigiosin isolated from the microorganism. The prodigiosin is useful as an immunosuppressive in various fields, including the treatment of the diseases requiring immunosuppression and the basic research for the diseases, the transplantation of the organs or tissues, and the immune cells.
Claims4
A method of using prodigiosin to suppress the immune response of T lymphocytes in a mammal comprising the step of:
- administering to said mammal an effective amount of said prodigiosin to suppress the immune response of T lymphocytes having the chemical formula (I) of
- wherein said prodigiosin has a molecular weight of 323 and is produced from Serratia marcescens B-1231 (Korean Collection for Type Cultures, Korean Research Institute of Bioscience and Biotechnology, Access No. KCTC 0386BP).
A method of suppressing the immune response of T lymphocytes in a patient for the transplantation of organs, tissues, or immune cells comprising the step of:
- administering to said patient an effective amount of prodigiosin to suppress the immune response of T lymphocytes having the chemical formula (I) of
- wherein said prodigiosin has a molecular weight of 323 and is produced from Serratia marcescens B-1231 (Korean Collection for Type Cultures, Korean Research Institute of Bioscience and Biotechnology, Access No. KCTC 0386BP).
Dependencies are inferred from the claim text.